Related Experiment Video
Updated: Jan 25, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis
Cynthia Van der Hauwaert1,2, François Glowacki3,4, Nicolas Pottier5,6
1EA 4483-IMPECS-IMPact of Environmental ChemicalS on Human Health, Univ. Lille, 59045 Lille CEDEX, France. cynthia.vanderhauwaert@gmail.com.
Abstract:
Fibrosis, or tissue scarring, is defined as the excessive, persistent and destructive accumulation of extracellular matrix components in response to chronic tissue injury. Renal fibrosis represents the final stage of most chronic kidney diseases and contributes to the progressive and irreversible decline in kidney function. Limited therapeutic options are available and the molecular mechanisms governing the renal fibrosis process are complex and remain poorly understood. Recently, the role of non-coding RNAs, and in particular microRNAs (miRNAs), has been described in kidney fibrosis. Seminal studies have highlighted their potential importance as new therapeutic targets and innovative diagnostic and/or prognostic biomarkers. This review will summarize recent scientific advances and will discuss potential clinical applications as well as future research directions.
Insights
This review explores non-coding RNAs, specifically microRNAs (miRNAs), in kidney fibrosis. These molecules show promise as therapeutic targets and biomarkers for chronic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Fibrosis, or tissue scarring, involves excessive extracellular matrix accumulation after chronic injury.
- Renal fibrosis signifies end-stage kidney disease, leading to irreversible function decline.
- Current therapeutic options for renal fibrosis are limited, with poorly understood mechanisms.
Purpose of the Study:
- To review recent advances in understanding non-coding RNAs in kidney fibrosis.
- To discuss the potential of microRNAs (miRNAs) as therapeutic targets and biomarkers.
- To explore future research directions and clinical applications.
Main Methods:
- Literature review of seminal studies on non-coding RNAs and kidney fibrosis.
- Analysis of recent scientific findings on miRNA roles in renal fibrosis.
- Synthesis of information on diagnostic and therapeutic potential.
Main Results:
- Non-coding RNAs, particularly miRNAs, play a significant role in kidney fibrosis.
- miRNAs are emerging as crucial regulators in the development of renal fibrosis.
- These molecules offer potential as biomarkers and therapeutic targets.
Conclusions:
- miRNAs represent a promising area for novel therapeutic strategies in renal fibrosis.
- Further research into miRNAs could lead to improved diagnostics and prognostics for kidney disease.
- Understanding miRNA involvement is key to developing effective treatments for renal fibrosis.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
piRNA - Piwi-interacting RNAs
Self Within Cultural Contexts
Nursing Code of Ethics

